US Stock MarketDetailed Quotes
TPST Tempest Therapeutics
Watchlist
0.387
-0.092-19.12% Close 09/22 16:00 ET
0.3870.0000.00%
Post 17:11 ET
0.480High0.380Low208.06KVolume
0.480Open0.479Pre Close84.62KTurnover2.76%Turnover RatioLossP/E (TTM)5.16MMarket Cap4.21452wk HighLossP/E (Static)13.32MShares0.38052wk Low1.03P/B2.92MFloat Cap260.100Historical High--Dividend TTM7.55MShs Float0.380Historical Low--Div YieldTTM20.90%Amplitude0.406Avg Price1Lot Size
About Tempest Therapeutics Company
Tempest Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development and discovery of small molecule drugs for the treatment of cancer. The company was founded in 2011 and is headquartered in Brisbane, CA.
Company Profile
SymbolTPST
Company NameTempest Therapeutics
Listing Date04/30/2013
Founded2011
CEOMr. Stephen R. Brady
MarketNASDAQ
Employees19
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2000 Sierra Point Parkway,Suite 400
CityBrisbane
ProvinceCalifornia
CountryUnited States of America
Zip Code94005
Websitehttp://www.tempesttx.com
Company Executives
No Data
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--